Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

It has been 12 years since the Allele Frequency Net Database (AFND; http://www.allelefrequencies.net) was first launched, providing the scientific community with an online repository for the storage of immune gene frequencies in different populations across the world. There have been a significant number of improvements from the first version, making AFND a primary resource for many clinical and scientific areas including histocompatibility, immunogenetics, pharmacogenetics and anthropology studies, among many others. The most widely used part of AFND stores population frequency data (alleles, genes or haplotypes) related to human leukocyte antigens (HLA), killer-cell immunoglobulin-like receptors (KIR), major histocompatibility complex class I chain-related genes (MIC) and a number of cytokine gene polymorphisms. AFND now contains >1400 populations from more than 10 million healthy individuals. Here, we report how the main features of AFND have been updated to include a new section on ‘HLA epitope’ frequencies in populations, a new section capturing the results of studies identifying HLA associations with adverse drug reactions (ADRs) and one for the examination of infectious and autoimmune diseases associated with KIR polymorphisms—thus extending AFND to serve a new user base in these growing areas of research. New criteria on data quality have also been included.

[1]  Gerhard Opelz,et al.  HLA matching and kidney transplantation: beyond graft survival. , 2013, Clinical transplants.

[2]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[3]  M. Marrari,et al.  16th IHIW: A Website for Antibody‐Defined HLA Epitope Registry , 2012, International journal of immunogenetics.

[4]  C Dosne Pasqualini,et al.  The HLA system. , 1979, Medicina.

[5]  Loren Gragert,et al.  The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans , 2011, Science.

[6]  M. Pirmohamed,et al.  HLA Genotype and Carbamazepine‐Induced Cutaneous Adverse Drug Reactions: A Systematic Review , 2012, Clinical pharmacology and therapeutics.

[7]  J. Klein,et al.  The HLA system. First of two parts. , 2000, The New England journal of medicine.

[8]  C-J Chen,et al.  A comprehensive 4‐year survey of adverse drug reactions using a network‐based hospital system , 2012, Journal of clinical pharmacy and therapeutics.

[9]  J. Klein,et al.  The HLA system. Second of two parts. , 2000 .

[10]  David Burgner,et al.  HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.

[11]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[12]  Andrew R. Jones,et al.  Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations , 2010, Nucleic Acids Res..

[13]  E. Thorsby,et al.  HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. , 2005, Transplant immunology.

[14]  Andrew R. Jones,et al.  A database for curating the associations between killer cell immunoglobulin-like receptors and diseases in worldwide populations , 2013, Database J. Biol. Databases Curation.

[15]  Munir Pirmohamed,et al.  Drug Induced Hypersensitivity and the HLA Complex , 2010, Pharmaceuticals.

[16]  J. Nowak,et al.  Role of HLA in hematopoietic SCT , 2008, Bone Marrow Transplantation.